PRINCETON, N.J., March 28 /PRNewswire/ -- Laureate Pharma, a full service biopharmaceutical development and protein production company, announced today that it has formally opened its newly constructed Pilot Plant in Princeton, NJ for pre-clinical biopharmaceutical manufacturing. The plant is now available for early engineering runs and production of product for uses such as formulation and toxicological testing.
The pilot plant is designed for process development, production and purification of early-phase preclinical proteins. The facility also features two separate production suites and two expanded purification suites to support pre-clinical production of recombinant proteins from mammalian-cell culture. The suites mimic Laureate’s already existing cGMP production facility and equipment. The pilot plant includes both stainless-steel, stirred-tank bioreactors and disposable, single-use bioreactors - the same technologies used in Laureate’s larger scale, cGMP manufacturing facility. The purification suites also feature the same process chromatography and filtration technologies used in the cGMP facility.
“The equipment in our pilot plant facility is designed to facilitate a direct, seamless scale-up from development to cGMP production for our clients’ projects,” said Robert Broeze, PhD, Laureate’s President and CEO. “With the new pilot plant in operation, we can accelerate our manufacturing of pre- clinical material and save on several months worth of critical product development time.”
About Laureate Pharma, Inc.
Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. Laureate offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. Laureate is a partner company of Safeguard Scientifics, Inc. , which builds value in growth-stage technology and life sciences businesses and provides growth capital as well as a range of strategic, operational and management resources to its partner companies (www.safeguard.com). For more information, contact Michael Cavanaugh, Vice President Sales, Marketing, and Business Development at (609) 919-3400, email info@laureatepharma.com or visit www.laureatepharma.com.
Laureate Pharma, Inc.
CONTACT: Michael Cavanaugh, Vice President Sales, Marketing, and BusinessDevelopment, +1-609-919-3400, email info@laureatepharma.com
Web site: http://www.laureatepharma.com//
